SOLV Solventum
- 59.340
- +0.990+1.70%
- 58.580
- -0.760-1.28%
Solventum News
Express News | NYSE Order Imbalance 378924.0 Shares on Buy Side
Express News | Solventum Corp : Goldman Sachs Initiates Coverage With Sell Rating; Price Target $54
Stock Ratings for Solventum and GE HealthCare Offer a Lesson About Spinoffs -- Barrons.com
Al Root The latest Wall Street ratings on the healthcare companies Solventum and GE HealthCare Technologies offer a master's class in what to look for in shares of spinoff companies -- and which of t
Solventum Initiated at Sell by Goldman Sachs
Solventum Initiated at Sell by Goldman Sachs
Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target
Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target.
Is 3M Spinoff Solventum a Buy? (And What It Means for 3M Investors)
It's always interesting when a new company comes to market and doubly interesting when it's a spinoff. In reality, two new companies came out of the spinoff of Solventum (SOLV -1.41%) and 3M (MMM 3.58%) -- a newly created healthcare company and an industrial conglomerate without a healthcare business.
3M's Stock Rises With Upgrade From Vertical Research
The 3M Dividend Cut Is Here. It's Big.
Post-it maker 3M declared a dividend of 70 cents, down from the prior quarter's $1.51 payout.
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight
Solventum | 10-Q: Quarterly report
Solventum Initiated at Neutral by B of A Securities
Solventum Initiated at Neutral by B of A Securities
Solventum Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 7.86% B of A Securities → $70 Initiates Coverage On → Neutral 04/10/2024 7.86% Morgan Stanley →
Express News | Solventum Corp : BofA Global Research Initiates Coverage With Neutral Rating; Price Objective $70
Maintaining Hold on Solventum: A Cautious Outlook on Long-Term Turnaround and Growth Prospects
Solventum Reports Earnings. There Will Be No Dividend. -- Barrons.com
Al Root Solventum, the 3M healthcare business, reported a better-than-expected first-quarter profit on Thursday. What the company said about capital allocation looks to be the bigger deal. Solventum
Solventum Q1 Adjusted Earnings Decline, Net Sales Increase
Solventum (SOLV) reported Q1 adjusted earnings Thursday of $2.08 per diluted share, down from $2.19 a year earlier. Two analysts surveyed by Capital IQ expected $1.75. Net sales for the quarter ended
Express News | Solventum Q1 2024 Adj EPS $2.08 Beats $1.75 Estimate, Sales $2.016B Miss $2.017B Estimate
Solventum 1Q Adj EPS $2.08 >SOLV
Solventum 1Q Adj EPS $2.08 >SOLV
Express News | Solventum Corp - Has Decided Not to Pay a Cash Dividend on Its Common Stock or Authorize Repurchase of Shares at This Time
Express News | Solventum Corp - 3M Supply Agreement Mark-up Started on April 1, Co Sees Impact to Income Statement to Begin Largely in the Second Half of 2024.
Analysis
Price Target
No Data
